Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia

Abstract

Argatroban anticoagulation, compared with historical control subjects, improves clinical outcomes in patients who have heparin-induced thrombocytopenia, without increasing bleeding risk.